This is despite the variation in overall CD107a expression levels that is a natural consequence of human donor variability. Open in a separate window Figure 4 pNK cell activation is augmented through ligation using nanoclustered antibodies in the form of NGO–hCD16. remedy of individual molecules. These results demonstrate that future immunotherapies could be enhanced by assembling immunomodulatory medicines into nanoclusters and set up NGO-templating as a candidate technology. Keywords: Bionanotechnology, biofunctional nanoparticles, graphene oxide, NK cell, immune cell activation Immunotherapies are revolutionizing malignancy treatments, Trichodesmine as the focus shifts from medicines that destroy tumors directly, toward harnessing the bodys natural immune defenses.1?3 Key players include leukocytes such as T?cells4,5 and closely related Natural Killer (NK) cells.6,7 These recognize target cells and communicate with other immune cells via intimate cellCcell contacts, known as immunological synapses.8?11 Importantly, the majority of interactions in immunological synapses are not between isolated ligandCreceptor pairs but rather involve clusters of cell surface molecules in the size range 10C400 nm.12?15 The size of these clusters correlates with cell signaling, and evidence is growing that such nanostructural changes may be key drivers of immune cell activation.13,15?19 However, the importance of nanoscale clustering has not fed through into immunotherapy biologic agents for activating immune cells. Monoclonal antibodies, for example, each bind only a single Fc receptor such as the NK cell activating receptor CD16. This can impact on signaling, for example, Rituximab, one of the best-characterized antibodies used medically, activates NK cells when it is bound to a surface such as the surface of a target cell (in this case a B cell), but only weakly induces activation as an unbound soluble reagent. Here, we have produced an acellular soluble reagent that exploits receptor nanoclustering to activate immune cells. This consists of artificial clusters of leukocyte-stimulating ligands that mimic immunoreceptor nanoclusters in terms of size and molecular quantity. Specifically, the ligand molecules are mounted on a scaffold of functionalized nanoscale graphene oxide (NGO). NGOs planar shape means that they can extend to large (>50 nm) sizes without imposing the razor-sharp curvatures associated with, for example, spherical nanoparticles, which would likely influence activation.20 Furthermore, NGO is functionalizable and variants have been proposed for drug delivery, diagnostics, and phototherapy.21?24 We have demonstrated the effectiveness of NGO-templated biomimetic nanoclusters as immune cell activating reagents in NK cells. Here, we focus on one of the best-characterized NK cell activating receptors, CD16, which recognizes the Fc portion of antibodies that have coated target cells, inducing target cell lysis (antibody-dependent cellular cytotoxicity, ADCC) and cytokine secretion. We 1st developed a protocol to prepare antibody-functionalized NGO bedding of high purity and colloidal stability with direct knowledge of sheet size and molecular quantity. This has been applied to generate NGO functionalized with monoclonal antibodies that bind human being CD16 with sheet size and molecular quantity in the correct range for cell surface receptor nanoclusters observed in super-resolution studies of leukocytes.12,13,15,25,26 These artificial nanoclusters are confirmed to specifically bind primary human being NK (pNK) cells via the CD16 receptor. Critically, they function as an activating reagent, enhancing NK cell effector functions in terms of both cytolytic reactions as indicated by improved levels of cell-surface CD107a, a marker of degranulation, and the secretion of the cytokine IFN-. Development of NGO-Templated Biomolecular Nanoclusters A key home of biomolecular nanoclusters in the immune synapse is definitely size, and our artificial nanoclusters should be synthesized in a realistic size range. Because super-resolution data on nanocluster sizes is only available for a few molecules, not currently including CD16, we chose to Trichodesmine construct nanoclusters having a median size (diameter) of Rabbit polyclonal to AURKA interacting 150 nm, related to that observed for the NK cell surface receptor KIR2DL115 and in the middle of the reported range for TCR nanoclusters in triggered T cells.12 This was achieved using NGO flakes (2D-Tech, Manchester, U.K.) with purification methods carried out postfunctionalization delivering a thin size distribution (observe below). A schematic of the chemical approach Trichodesmine we developed to construct NGO-templated antibody nanoclusters is definitely given in Number ?Number11a with nanocluster characterization shown in Number ?Number11bCg. Because our goal was to deliver a soluble activation system, and unfunctionalized NGO is definitely unstable in salt concentrations of biological relevance, the 1st requirement was to functionalize the NGO having a stabilizing poly(ethylene glycol) (PEG) covering. PEG is definitely widely used to protect bionanomaterials from flocculation and nonspecific interactions with proteins. PEGylated NGO specifically has been shown to be viable for in vivo applications with low toxicity and effective long-term clearance27 as have other highly purified NGO materials.28 Here, PEG-coating was achieved by first coupling carboxylic acid groups to the NGO surface and then binding amine-terminated PEG via EDC-activation of the carboxylic acid groups. Looking directly at colloidal stability, 8-arm celebrity PEG (< 0.05, ** < 0.01 (two-tailed paired parametric < 0.05), demonstrating the binding is mediated from the specificity of the -hCD16 antibody. The same qualitative result is definitely observed for the smaller 72 nm NGO--hCD16.
